Rapt Therapeutics Inc (RAPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | N/A | 47,517 |
| Other current assets | 0 | 0 | 0 | 0 | 725 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $48,242 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 236 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $236 |
| Total Assets | $N/A | $N/A | $N/A | $N/A | $50,391 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 1,106 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 1,492 |
| Other current liabilities | N/A | N/A | N/A | N/A | 650 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $3,248 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 905 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $905 |
| Total Liabilities | $N/A | $N/A | $N/A | $N/A | $4,153 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | N/A | 1 |
| Retained earnings | N/A | N/A | N/A | N/A | -82,806 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 108,038 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $46,238 |
| Total Liabilities And Equity | $0 | $0 | $0 | $0 | $50,391 |